Loading…
Loading…
ALRTF does not currently pay a dividend.
See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.
Click below to see what's inside, then upgrade to unlock for ALRTF and 80,000+ other tickers.
See exactly how ALRTF's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.
The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for ALRTF and 80,000+ other tickers.
ALR Technologies Inc. is a data management company dedicated to creating and providing diabetes care solutions for both human and animal health sectors across the United States. Central to its offerings is the comprehensive Diabetes Management System. This system facilitates data collection, provides predictive A1C analysis, offers recommendations for insulin dosage adjustments, tracks performance, enables remote patient monitoring, and supplies essential diabetes testing materials. The company also markets Continuous Glucose Monitoring (CGM) devices, which are wearable medical technologies…
ALR Technologies Announces Strategic Acquisition of CGM Medical Technology for US$45 Million and 200M Shares PR Newswire
SINGAPORE, June 30, 2026 /PRNewswire/ -- ALR Technologies SG Ltd ("ALRT" or the "Company") (OTC: ALRTF), the diabetes management company, announces it has entered into a Letter of Intent ("LOI") to acquire 100% equity of CGM Medical Technology Singapore Pte. Ltd. ("CGM Medical Singapore") and assets of CGM Medical Technology Shenzhen Ltd ("CGM Medical Shenzhen") for an aggregate purchase price of 200 million ordinary shares and US$45 million, payable upon certain conditions being met (collectively the "Transactions").
SINGAPORE, May 19, 2026 /PRNewswire/ -- ALR Technologies SG Ltd. ("ALRT" or the "Company") (OTC: ALRTF), the diabetes management company, announces the GluCurve Pet CGM ("GluCurve") is now for sale in Canada at www.GluCurve.ca.
SINGAPORE , Dec. 8, 2025 /PRNewswire/ -- ALR Technologies SG Ltd ("ALRT" or the "Company") (OTC: ALRTF), the diabetes management company, announces the successful completion of internal manufacturing testing on the GluCurve Pet CGM ("GluCurve") showing accuracy results comparative to the leading veterinary Blood Glucose Meter ("BGM") and scheduling of its relaunch into the Canadian market for January 2026. GluCurve is the first and only diabetic monitoring system built specifically for veterinary use on cats and dogs.
SINGAPORE , June 25, 2025 /PRNewswire/ -- ALR Technologies SG Ltd. ("ALRT" or the "Company") (OTCPK: ALRTF), the diabetes management company, announces it has entered into a Definitive Manufacturing Agreement with CGM Medical Technology Shen Zhen Ltd.